logo
15:55 Dec 05

Bal Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
71.47
-2.90 (-3.90%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Bal Pharma Ltd. Financials

Bal Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
71.47
-2.90 (-3.90%)
15:55 Dec 05
Quality
image/svg+xml

45/100
Medium Financial Strength

Valuation
image/svg+xml

56/100
Affordable Valuation

Technical

30/100
Technically Bearish

Strength

5

Weakness

7

Opportunity

1

Threats

0

9.32 %

ROE %

2.14 %

ROA %

4.29

EPS

48.62

BVPS

2.38 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
281.21 304.22 339.22 303.08 294.59
Operating Expenses +
257.73 279.09 307.69 273.53 265.42
Raw Material
172.42 190.64 192.82 164.95 165.49
Increase Decrease in Cost
-4.89 -17.87 -1.06 -7.05 -13.14
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
47.25 55.3 60.38 62.4 62.29
Miscellaneous Expenses
59.81 73.92 78.03 83.35 50.78
Operating Profit
23.48 25.13 31.53 29.55 29.17
Other Income
5.15 0.94 2.85 2.2 2.11
Depreciation
9.04 9.13 10.07 9.77 9.87
Interest
10.41 12.19 15.26 16.85 16.66
Profit before tax and exceptio..
9.18 4.75 9.05 5.14 4.75
Exceptional Items
0 0 0 0 0
PBT
9.18 4.75 9.05 5.14 4.75
Provision for Taxation
3.48 2.13 1.6 -2.1 -2.46
Net Profit
5.7 2.62 7.45 7.24 7.19
NET Profit after MI
5.61 2.57 7.39 7.22 7.15
EPS
3.79 1.67 4.94 4.54 4.51
Operating Profit Margin (%)
8.35 8.26 9.29 9.75 9.9
Net Profit Margin (%)
2 0.84 2.18 2.38 2.43

Bal Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 50.90 50.90 50.90 50.90 50.90 51.20
FII 0.20 0.20 0.10 0.10 0.10 0.10
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 48.90 48.90 49.00 49.00 49.00 48.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: